Vantage Health 51% Owned Tanzanian Subsidiary Awarded Lot 1, Lot 2 and Lot 3 of University of Dar Es Salaam Pharmaceutical and Medical Supply...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K /A [X] ANNUAL REPORT UNDER SECTION 13 OR...
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Mark One [ X] QUARTERLY REPORT PURSUANT TO SECTION...
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number: 333-168930 ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d...
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 333-168930...
Vantage Health Announces That All of Its Required Tanzanian Registrations, Permits and Licenses Have Been Formally Issued, Simultaneous With...
Vantage Health Submits Tender Documents for Tanzania Medical Stores Department and University of Dar es Salaam Procurement Tenders PR...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE...
Vantage Health South African Subsidiary Negotiates Supply Agreement With Major South African Retail Group PR Newswire CAPE TOWN, South Africa...
Vantage Health Announces Plan to Establish Pharmaceutical Plant, Hospital in the Kingdom of Swaziland, in Partnership With Swaziland...
Tanzania Minister of Health, on Behalf of the Government, Promises Full Support to Vantage Health in the United Republic of Tanzania PR...
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Mark One X . QUARTERLY REPORT PURSUANT TO SECTION 13...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.